• 1
    Baker T. B., Breslau N., Covey L., Shiffman S. DSM criteria for tobacco use disorder and tobacco withdrawal: a critique and proposed revisions for DSM-5. Addiction 2012; 107: 26375.
  • 2
    Fagerstrom K. Determinants of tobacco use and renaming the FTND to the Fagerström Test for Cigarette Dependence. Nicotine Tob Res 2011; Epub ahead of print 24 October.
  • 3
    Fagerström K., Gilljam H., Metcalfe M., Tonstad S., Messig M. Stopping smokeless tobacco with varenicline: randomised double blind placebo controlled trial. BMJ 2010 341:c6549. doi: 10.1136/bmj.c6549.
  • 4
    Ebbert J. O., Croghan I. T., Siversen H., Schroeder D. R., Hays T. T. A pilot study of the efficacy of varenicline for the treatment of smokeless tobacco users in Midwestern United States. Nicotine Tob Res 2011; 13: 8206.
  • 5
    Thomas J. L., Ebbert J. O., Patten C. A., Bronars C. A., Schroeder D. R. Measuring nicotine dependence among smokeless tobacco users. Addict Behav 2006; 31:151121.
  • 6
    Fagerström K., Russ C., Yu C-R., Yunis C., Foulds J. The Fagerström Test for Nicotine Dependence as a Predictor of Smoking Abstinence: A Pooled Analysis of Varenicline Clinical Trial Data. Nicotine Tob Res 2011; in press.
  • 7
    Fagerström K., Kunze M., Schoberberger R., Breslau N., Hughes J. R., Hurt R. D. et al . Nicotine dependence versus smoking prevalence: comparisons among countries and categories of smokers. Tob Cont 1996; 5: 526.
  • 8
    Fidler J. A., Shahab L., West R. Strength of urges to smoke as a measure of severity of cigarette dependence: comparison with the Fagerstrom Test for Nicotine Dependence and its components. Addiction 2011; 106: 6318.